sitagliptin "mylan" 100 mg filmovertrukne tabletter
mylan ab - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg
sitagliptin "mylan" 50 mg filmovertrukne tabletter
mylan ab - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg
sitagliptin/metforminhydrochlorid "medical valley" 50+1000 mg filmovertrukne tabletter
medical valley invest ab - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
sitagliptin "laurus" 100 mg filmovertrukne tabletter
laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg
sitagliptin "laurus" 50 mg filmovertrukne tabletter
laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg
sitagliptin/metforminhydrochlorid "pharmazac" 50+1000 mg filmovertrukne tabletter
pharmazac s.a. - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
sitagliptin/metforminhydrochlorid "pharmazac" 50+850 mg filmovertrukne tabletter
pharmazac s.a. - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+850 mg
sitagliptin "reddy" 100 mg filmovertrukne tabletter
reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg
sitagliptin "reddy" 50 mg filmovertrukne tabletter
reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg
trulicity
eli lilly nederland b.v. - dulaglutide - diabetes mellitus, type 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for undersøgelsens resultater med hensyn til kombinationer, effekt på glykæmisk kontrol og hjerte-kar-hændelser, og de befolkninger, der studerede, se afsnit 4. 4, 4. 5 og 5.